Atom Investors LP purchased a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 4,339 shares of the financial services provider’s stock, valued at approximately $358,000.
A number of other hedge funds and other institutional investors have also modified their holdings of the company. MeadowBrook Investment Advisors LLC boosted its position in shares of MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. boosted its position in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 186 shares during the last quarter. Wolff Wiese Magana LLC boosted its position in shares of MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 277 shares during the last quarter. Peterson Financial Group Inc. acquired a new stake in shares of MetLife in the third quarter worth approximately $30,000. Finally, Fortitude Family Office LLC boosted its position in shares of MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 266 shares during the last quarter. 89.81% of the stock is currently owned by hedge funds and other institutional investors.
MetLife Trading Down 0.4 %
NYSE MET opened at $85.35 on Thursday. The company’s fifty day simple moving average is $83.65 and its 200-day simple moving average is $76.85. MetLife, Inc. has a 52 week low of $63.19 and a 52 week high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a market cap of $59.10 billion, a P/E ratio of 17.21, a PEG ratio of 0.80 and a beta of 1.06.
MetLife Dividend Announcement
Wall Street Analyst Weigh In
MET has been the topic of several research analyst reports. Jefferies Financial Group raised their target price on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 27th. Barclays reduced their price target on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday, October 31st. Wells Fargo & Company lifted their price target on shares of MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. TD Cowen lifted their price target on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, November 27th. Finally, Morgan Stanley reduced their price target on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, August 19th. Fourteen research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $88.62.
Get Our Latest Stock Report on MET
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- The Risks of Owning Bonds
- Tesla Poised to Hit Record Highs This Holiday Season
- Conference Calls and Individual Investors
- The Salesforce Rally is Just Getting Started: Here’s Why
- How to Buy Cheap Stocks Step by Step
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.